Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 21 Dec 22 424B5 Prospectus supplement for primary offering
- 28 Apr 22 EFFECT Notice of effectiveness
- 22 Mar 22 POS AM Prospectus update (post-effective amendment)
- 21 Mar 22 POSASR Automatic shelf registration (post-effective amendment)
- 6 May 21 424B5 Prospectus supplement for primary offering
-
6 May 21 S-3ASR Automatic shelf registration
ORIC similar filings
Filing view
External links
Exhibit 23.2
Consent of Independent Registered Public Accounting Firm
The Board of Directors
ORIC Pharmaceuticals, Inc.:
We consent to the use of our report dated March 23, 2021, incorporated by reference herein and to the reference to our firm under the heading “Experts” in the prospectus.
/s/ KPMG LLP
San Diego, California
May 6, 2021